Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

This Dividend Stock Is Outperforming the S&P 500, Nasdaq, and Dow Jones This Year -- Is It a Buy?


With all the noise surrounding artificial intelligence (AI) and the attention it has brought to the "Magnificent Seven" and growth stocks, a number of value and dividend stocks have flown under the radar. One company in particular that hasn't gotten much attention is AT&T (NYSE: T).

So far in 2024, AT&T has had one of its best years in recent times. It's outperforming all three major indexes, something we haven't been able to say for quite a while. It's not mildly outperforming them, either; there's some considerable distance between their returns.

T Total Return Level Chart

Continue reading


Source Fool.com

Allergy Therapeutics PLC Aktie

0,042 €
-11,70 %
Allergy Therapeutics PLC muss heute herbe Verluste wegstecken. Die Aktie notiert im Vergleich zu gestern um -11,70 % tiefer.

Like: 0
T
Teilen

Kommentare